An after market announcement revealed the name chosen for its lead compound SBP02 , its Coramsine.
After 3 years in this stock I give up. Why don t they pay for proper marketing and start running the company on a professional basis .
After a couple of restructures over the last few years the stock continues to lanquish with dog status . The SBP compound in itself is a fantastic product with unlimited potential, it just needs the NRT board running it.
No doubt there will be some efforts to promote the share before the AGM to make the directors look good and lessen the awkward questions .
SBP
solbec pharmaceuticals limited
